Vitamin D as an Early Predictor of Multiple Sclerosis Activity and Progression
Alberto Ascherio1, Kassandra L. Munger1, Rick White2, Karl Köchert3, C. Simon1, Chris H. Polman4, Mark S. Freedman5, Hans‐Peter Hartung6, David H. Miller7, Xavier Montalbán8, Gilles Edan9, Frederik Barkhof4, Dirk Pleimes10, Ernst-Wilhelm Radü11, Rupert Sandbrink12, Ludwig Kappos11, Christoph Pohl13
1Harvard School of Public Health, Boston, Massachusetts
2University of British Columbia, Vancouver, Canada
3Bayer Healthcare, Berlin, Germany
4VU University Medical Center, Amsterdam, The Netherlands
5Ottawa Hospital Research Institute, Ottawa, Canada
6Heinrich-Heine-Universitat, Dusseldorf, Germany
7University College London Institute of Neurology, London, England.
8Hospital Universitari Vall d’Hebron, Barcelona, Spain
9CHU-Hôpital Pontchaillou, Rennes, France
10Bayer HealthCare Pharmaceuticals, Montville, New Jersey
11University Hospital Basel, Basel, Switzerland
12Bayer HealthCare, Berlin, Germany6Heinrich-Heine Universität, Düsseldorf, Germany
13Bayer HealthCare, Berlin, Germany12Department of Neurology, University Hospital of Bonn, Bonn, Germany.
Tóm tắt
Từ khóa
Tài liệu tham khảo
Thông tin
Thông tin xuất bản
JAMA Neurology
Tập 71 Số 3
306
Thông tin tác giả